Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Review: protein repair as an overlooked part of proteostasis in aging

This review argues that enzymatic protein repair is more widespread and important than long assumed, and links failing repair to age-related diseases. It is a mechanistic framework, not new measurements. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The review says enzymatic protein repair is more widespread and functionally significant than previously appreciated, based on evidence from prokaryotic and eukaryotic systems. [1]

  2. The authors propose that repair is selectively deployed when replacement is inefficient or deleterious. [1]

  3. The review links progressive failure of protein repair to proteome instability and cellular dysfunction in age-related diseases. [1]

The source at a glance

Study type / format
Narrative review (abstract only)
Population / context
Not applicable; a conceptual review of protein damage and repair across prokaryotic and eukaryotic systems and age-related diseases.
Summary based on
Study abstract
Original publication
October 8, 2026

Review reframes damaged proteins as repairable

The authors note that proteins were long seen as largely disposable rather than repairable, shaping the usual proteostasis view in which damaged proteins are mainly removed and replaced. Evidence from prokaryotic and eukaryotic systems, they say, shows enzymatic protein repair is more widespread and functionally significant than previously appreciated. They therefore treat repair as a distinct, under-recognized part of proteostasis that complements degradation and resynthesis.

Supporting source [1]

Damage types mapped to matching repair systems

The review offers a mechanistic framework pairing major forms of protein damage — oxidation, nitration, chlorination, glycation and spontaneous isomerization — with their corresponding repair systems. The authors argue that the apparent scarcity of repair pathways reflects biochemical complexity, energetic cost and the heterogeneity of damaged substrates, not their absence. They also propose that repair is used selectively when replacement is inefficient or harmful, discussing trade-offs between repair and turnover.

Supporting source [1]

Proposed link from repair failure to age-related disease

The authors connect these mechanisms to the pathogenesis of major age-related diseases, including neurodegenerative, cardiovascular and metabolic disorders, and cancer. They suggest that progressive failure of protein repair contributes to proteome instability and cellular dysfunction. The review also outlines emerging opportunities for therapeutic intervention targeting protein damage in aging and disease. These are proposed interpretations and perspectives, not demonstrated treatments or measured outcomes.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a review presenting a mechanistic framework and perspectives, not new experimental data, so the disease links and therapeutic opportunities are proposed interpretations rather than demonstrated causal or clinical findings.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Protein damage and repair in aging: Mechanisms, homeostasis and disease.

Lyakhovich A, Ferrucci L. · europepmc.org · October 8, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    more widespread and functionally significant than previously
  2. Finding 2 ↑

    repair is selectively deployed under conditions where
  3. Finding 3 ↑

    progressive failure of protein repair contributes to

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…